Brooklyn ImmunoTherapeutics Inc News - BTX

Current Report Filing (8-k)

false000074859200007485922022-09-092022-09-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement...

Proxy Statement (definitive) (def 14a)

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A INFORMATIONProxy Statement Pursuant to...

Quarterly Report (10-q)

false12-312022Q20000748592P5Y6MP15D00007485922022-01-012022-06-3000007485922022-08-1000007485922022-06-300000748...

Current Report Filing (8-k)

false000074859200007485922022-08-012022-08-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

false000074859200007485922022-07-212022-07-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

false000074859200007485922022-06-272022-06-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

false000074859200007485922022-06-162022-06-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

false000074859200007485922022-06-052022-06-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Brooklyn ImmunoTherapeutics Inc (BTX)

Professional-Grade Tools, for Individual Investors.

BTX News

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Quarterly Report (10-q)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Initial Statement of Beneficial Ownership (3)

Initial Statement of Beneficial Ownership (3)

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Initial Statement of Beneficial Ownership (3)

Initial Statement of Beneficial Ownership (3)

Additional Proxy Soliciting Materials (definitive) (defa14a)

BTX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Brooklyn ImmunoTherapeutics Inc (BTX) News

Brooklyn ImmunoTherapeutics Inc (BTX)

Professional-Grade Tools, for Individual Investors.

BTX News

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Quarterly Report (10-q)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Initial Statement of Beneficial Ownership (3)

Initial Statement of Beneficial Ownership (3)

Current Report Filing (8-k)

Statement of Changes in Beneficial Ownership (4)

Initial Statement of Beneficial Ownership (3)

Initial Statement of Beneficial Ownership (3)

Additional Proxy Soliciting Materials (definitive) (defa14a)

BTX Discussion

Your Recent History